Context Therapeutics Inc. — Director's Dealing 2021

Oct 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2021-10-22

Reporting Person: Dick Evan G. (SVP of R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-22	Common Stock	C	26587	—	Acquired	87139	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-22	Series Seed Preferred Stock	$	C	26587	Disposed		Common Stock (26587)	Direct

Footnotes

F1: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.

F2: Includes 39,659 restricted stock units which fully vest on February 24, 2023.

F3: Fully vested.